Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Class Warfare: CMS Proposes Sweeping Changes to Part D; “Protected Class” Cuts Just the Start

This article was originally published in RPM Report

Executive Summary

The Centers for Medicare & Medicaid Services is celebrating the 10th anniversary of Part D by proposing the most sweeping changes to the Medicare drug benefit since it launched. Proposed revisions to the “Protected Classes” will get the most attention, but the rest of the rule may have more profound impacts going forward.


Related Content

CMS Returns To Part D Rule, But Steers Clear of Controversial Policies
“Non-Interference” And Part D: Prescriber Oversight Is Focus Of CMS Final Rule
Part D Proposed Rule Gone But Not Forgotten: Bill Would Bring “Any Willing Pharmacy” Provision Back
The Part D Premium Lesson For Exchanges
So That's What "Non-Interference" Means: CMS Defines Loaded Term in Proposed Part D Rule
CMS Wades Into the Opioid Debate
Humana-Mart: The New Part D Plan Raises More Questions Than Answers
Protected Class Lobbying Begin
Keeping the Government at Bay: Protecting Part D from the Protected Classes and Specialty Drug Pricing
Medicare's Privileged Drug Classes: Price Protections Through 2007


Related Companies




Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts